Skip to content
Screener

Labcorp Holdings LH Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

Azenta logo
AzentaAZTA
$3.95M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$8.72M-32.1%
Castle Biosciences logo
Castle BiosciencesCSTL
$0
IQVIA logo
IQVIAIQV
$50M+35.1%
Natera, Inc. logo
Natera, Inc.NTRA
$6.53M
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$28K

Segments

By segment

See full
Biopharma Laboratory Services$36.4M-18.6%

Other financials

Income statement

See full
Revenue$3.7B+5.8%
Gross profit$1.1B+6.3%
Operating income$451.6M+14.5%
Net income$298.7M+25.6%
EPS (diluted)$3.64+28.2%

Balance sheet

See full
Cash & equivalents$141.8M-78.1%
Total debt$6.8B+11.8%
Total equity$8.6B+1.6%
Total assets$18.5B+2.6%

Cash flow

See full
Operating cash flow$445.5M-28.2%
CapEx$121.0M-4.0%
Free cash flow$313.9M-42.2%

Valuation

See full
Market cap$26.06B+17.2%
Enterprise value$32.68B+18.2%
P/E26×-3.1×
P/S1.8×+0.2×

Profitability

See full
Gross margin28.9%+0.7pp
Operating margin10.4%+1.6pp
Net margin7%+1.3pp
FCF margin8.1%-1.3pp

Returns & leverage

See full
Return on equity11.7%+2.5pp
Debt / equity0.8×+0.1×
Current ratio1.8×+0.3×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.

The source filing: Labcorp Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 2:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000920148-26-000139
Line itemMarch 31, 2026December 31, 2025
Dx accounts receivable$1,513.2$1,349.0
BLS accounts receivable808.4791.2
Less: BLS allowance for credit losses(33.0)(36.4)
Accounts receivable, net$2,288.6$2,103.8
Gross unbilled services$166.2$164.0
Less: BLS allowance for credit losses(4.3)(7.1)
Unbilled services, net$161.9$156.9

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Labcorp Holdings's allowance for doubtful accounts receivable (current)?
Labcorp Holdings (LH) reported allowance for doubtful accounts receivable (current) of $33M in Q1 2026.
How has Labcorp Holdings's allowance for doubtful accounts receivable (current) changed year-over-year?
Labcorp Holdings's allowance for doubtful accounts receivable (current) decreased by 14.5% year-over-year, from $38.6M to $33M.
What is the long-term trend for Labcorp Holdings's allowance for doubtful accounts receivable (current)?
Over 5 years (2020 to 2025), Labcorp Holdings's allowance for doubtful accounts receivable (current) has grown at a 10.5% compound annual growth rate (CAGR), from $22.1M to $36.4M.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about Labcorp Holdings's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude